Position in MEDP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$587,844
New position
Shares Held
1,110
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#382
of 691 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $3,045,618 across 9 Diagnostics & Research names. MEDP ranks #3 (19.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
|
3,741 | $1,047,480 | |
| 2 | DGX |
Quest Diagnostics Inc
|
4,707 | $997,648 | |
| 3 | MEDP |
Medpace Holdings, Inc.
This page
|
1,110 | $587,844 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
452 | $226,614 | |
| 5 | DHR |
Danaher Corp /De/
|
674 | $128,383 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
69 | $36,324 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
100 | $19,322 | |
| 8 | NTRA |
Natera, Inc.
|
6 | $1,628 |
All Filings in MEDP
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $587,844 | 1,110 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||